Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,631,703
-$846,019 QoQ
Shares Held
22,380
-24.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,243
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $33,612,604 across 12 Drug Manufacturers - General names. ABBV ranks #2 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,377 | $11,247,056 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
22,380 | $5,631,703 | |
| 3 | JNJ |
Johnson & Johnson
|
20,128 | $5,111,908 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,013 | $3,728,170 | |
| 5 | PFE |
Pfizer Inc
|
94,107 | $2,266,096 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
34,471 | $1,986,219 | |
| 7 | AMGN |
Amgen Inc
|
4,406 | $1,595,500 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,409 | $809,713 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,631,703 | 22,380 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6,477,722 | 29,784 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,055,542 | 30,879 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,774,080 | 11,981 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,823,280 | 15,210 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,412,242 | 16,286 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,011,659 | 16,948 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,074,566 | 15,569 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,718,763 | 15,851 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,064,014 | 16,826 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,246,910 | 14,499 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,181,940 | 14,638 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,999,662 | 14,842 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,426,248 | 15,224 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,413,806 | 14,936 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $2,088,978 | 15,565 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,217,585 | 21,008 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $4,917,606 | 30,335 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,875,283 | 28,621 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $3,244,513 | 30,078 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,798,991 | 24,849 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,653,662 | 24,521 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $2,695,036 | 25,152 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $2,142,276 | 24,458 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,699,103 | 17,306 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,396,410 | 18,328 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||